A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

Клики: 506
ID: 112328
2003
Бесплатный PDF
Метрики качества и эффективности статьи
Общее качество
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
Оценка качества ИИ
Не проанализировано
Readership in this journal
Steady

Ranked #21 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Аннотация
Vaccination with a 9-valent pneumococcal conjugate vaccine reduced the incidence of radiologically confirmed pneumonia. The vaccine also reduced the incidence of vaccine-serotype and antibiotic-resistant invasive pneumococcal disease among children with and those without HIV infection.
Ссылочный ключ
kp2003thea Используйте этот ключ для автоцитирования в рукописи при использовании SciMatic Manuscript Manager или Thesis Manager
Авторы Klugman KP;Madhi SA;Huebner RE;Kohberger R;Mbelle N;Pierce N; ;;
Журнал The New England journal of medicine
Год 2003
DOI
DOI не найден
URL
http://www.ncbi.nlm.nih.gov/pubmed/14523142
Ключевые слова
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant Clinical Trial Randomized Controlled Trial Double-Blind Method Incidence Bacterial drug resistance hiv infections / complications* pneumonia vaccines serotyping pneumococcal infections / mortality pneumococcal infections / prevention & control* pmid:14523142 doi:10.1056/nejmoa035060 keith p klugman shabir a madhi vaccine trialists group bacterial capsules haemophilus vaccines pneumococcal vaccines* / adverse effects pneumococcal / prevention & control polysaccharides streptococcus pneumoniae / classification streptococcus pneumoniae / isolation & purification conjugate / adverse effects

Цитирования

Цитирования не найдены. Чтобы добавить цитирование, свяжитесь с администратором по адресу info@scimatic.org

Комментарии

Комментариев пока нет. Будьте первым, кто прокомментирует эту статью.